KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TAK) Return on Assets (2018 - 2025)

Historic Return on Assets for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to 0.14%.

  • Takeda Pharmaceutical's Return on Assets rose 300.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.14%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.01% for FY2025, which is 0.0% changed from last year.
  • Takeda Pharmaceutical's Return on Assets amounted to 0.14% in Q4 2025, which was up 300.0% from 0.15% recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Return on Assets high stood at 0.15% for Q2 2025, and its period low was 0.03% during Q2 2023.
  • For the 5-year period, Takeda Pharmaceutical's Return on Assets averaged around 0.07%, with its median value being 0.06% (2021).
  • As far as peak fluctuations go, Takeda Pharmaceutical's Return on Assets crashed by -300bps in 2023, and later skyrocketed by 900bps in 2025.
  • Takeda Pharmaceutical's Return on Assets (Quarter) stood at 0.05% in 2021, then decreased by -15bps to 0.05% in 2022, then skyrocketed by 36bps to 0.06% in 2023, then surged by 70bps to 0.11% in 2024, then soared by 33bps to 0.14% in 2025.
  • Its Return on Assets was 0.14% in Q4 2025, compared to 0.15% in Q3 2025 and 0.15% in Q2 2025.